

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | polyketide metabolic process (GO:0030638) | 9.51330768 |
| 2 | doxorubicin metabolic process (GO:0044598) | 9.51330768 |
| 3 | daunorubicin metabolic process (GO:0044597) | 9.51330768 |
| 4 | protein localization to kinetochore (GO:0034501) | 6.33586248 |
| 5 | maintenance of protein location in nucleus (GO:0051457) | 6.09237042 |
| 6 | aminoglycoside antibiotic metabolic process (GO:0030647) | 6.05362791 |
| 7 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.80416174 |
| 8 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 5.64763411 |
| 9 | regulation of telomere maintenance via telomerase (GO:0032210) | 5.61520860 |
| 10 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 5.60869441 |
| 11 | histone H4-K12 acetylation (GO:0043983) | 5.58893206 |
| 12 | somite rostral/caudal axis specification (GO:0032525) | 5.56958850 |
| 13 | regulation of response to osmotic stress (GO:0047484) | 5.48048909 |
| 14 | negative regulation of telomerase activity (GO:0051974) | 5.37683987 |
| 15 | mitotic sister chromatid segregation (GO:0000070) | 5.30543276 |
| 16 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 5.15965754 |
| 17 | histone H4-K8 acetylation (GO:0043982) | 5.14957730 |
| 18 | histone H4-K5 acetylation (GO:0043981) | 5.14957730 |
| 19 | negative regulation of epidermis development (GO:0045683) | 5.10597164 |
| 20 | positive regulation by symbiont of host defense response (GO:0052509) | 4.95669664 |
| 21 | modulation by symbiont of host defense response (GO:0052031) | 4.95669664 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.95669664 |
| 23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.95669664 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.95669664 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 4.95669664 |
| 26 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.89081020 |
| 27 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.88795737 |
| 28 | negative regulation of cell killing (GO:0031342) | 4.88536855 |
| 29 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.88536855 |
| 30 | rRNA transcription (GO:0009303) | 4.86626219 |
| 31 | protein localization to chromosome, centromeric region (GO:0071459) | 4.83358516 |
| 32 | heterochromatin organization (GO:0070828) | 4.70580904 |
| 33 | muscle organ morphogenesis (GO:0048644) | 4.66871167 |
| 34 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.63245046 |
| 35 | sister chromatid segregation (GO:0000819) | 4.47258568 |
| 36 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 4.45973438 |
| 37 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.45361110 |
| 38 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.39471443 |
| 39 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.39036145 |
| 40 | interferon-gamma production (GO:0032609) | 4.36466152 |
| 41 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.36290289 |
| 42 | negative regulation of telomere maintenance (GO:0032205) | 4.34336312 |
| 43 | DNA replication-dependent nucleosome organization (GO:0034723) | 4.32501535 |
| 44 | DNA replication-dependent nucleosome assembly (GO:0006335) | 4.32501535 |
| 45 | DNA replication checkpoint (GO:0000076) | 4.31818834 |
| 46 | chromatin assembly (GO:0031497) | 4.21431339 |
| 47 | nuclear pore complex assembly (GO:0051292) | 4.17620717 |
| 48 | notochord development (GO:0030903) | 4.17327914 |
| 49 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.17033494 |
| 50 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.09924313 |
| 51 | neutrophil activation involved in immune response (GO:0002283) | 4.06442468 |
| 52 | regulation of translation in response to stress (GO:0043555) | 4.04785695 |
| 53 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.01044807 |
| 54 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.97409352 |
| 55 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.95402000 |
| 56 | cytidine metabolic process (GO:0046087) | 3.93870566 |
| 57 | cytidine catabolic process (GO:0006216) | 3.93870566 |
| 58 | cytidine deamination (GO:0009972) | 3.93870566 |
| 59 | tolerance induction (GO:0002507) | 3.93746050 |
| 60 | NIK/NF-kappaB signaling (GO:0038061) | 3.93243701 |
| 61 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.92458747 |
| 62 | histone H4-K16 acetylation (GO:0043984) | 3.90891422 |
| 63 | regulation of cilium movement (GO:0003352) | 3.89430386 |
| 64 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.88568905 |
| 65 | macrophage activation involved in immune response (GO:0002281) | 3.88029195 |
| 66 | response to peptidoglycan (GO:0032494) | 3.87517515 |
| 67 | regulation of gamma-delta T cell activation (GO:0046643) | 3.86369248 |
| 68 | rRNA methylation (GO:0031167) | 3.85079407 |
| 69 | leukocyte aggregation (GO:0070486) | 3.85017346 |
| 70 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.84392893 |
| 71 | pre-miRNA processing (GO:0031054) | 3.82247753 |
| 72 | nucleoside transmembrane transport (GO:1901642) | 3.80922144 |
| 73 | primitive streak formation (GO:0090009) | 3.79026238 |
| 74 | nuclear pore organization (GO:0006999) | 3.75025013 |
| 75 | detection of other organism (GO:0098543) | 3.73357107 |
| 76 | detection of bacterium (GO:0016045) | 3.73259108 |
| 77 | positive regulation of protein deacetylation (GO:0090312) | 3.69365731 |
| 78 | RNA stabilization (GO:0043489) | 3.66891829 |
| 79 | mRNA stabilization (GO:0048255) | 3.66891829 |
| 80 | trophectodermal cell differentiation (GO:0001829) | 3.65356661 |
| 81 | rRNA modification (GO:0000154) | 3.62751676 |
| 82 | transcription from mitochondrial promoter (GO:0006390) | 3.59996596 |
| 83 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.57149203 |
| 84 | positive thymic T cell selection (GO:0045059) | 3.55528806 |
| 85 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.53990597 |
| 86 | retinoic acid receptor signaling pathway (GO:0048384) | 3.53888820 |
| 87 | thymic T cell selection (GO:0045061) | 3.51350260 |
| 88 | immunoglobulin mediated immune response (GO:0016064) | 3.49612763 |
| 89 | response to muramyl dipeptide (GO:0032495) | 3.47835657 |
| 90 | negative thymic T cell selection (GO:0045060) | 3.47156779 |
| 91 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.44172783 |
| 92 | maintenance of protein localization in organelle (GO:0072595) | 3.43779152 |
| 93 | regulation of gene silencing by miRNA (GO:0060964) | 3.42453558 |
| 94 | regulation of gene silencing by RNA (GO:0060966) | 3.42453558 |
| 95 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.42453558 |
| 96 | positive regulation of histone deacetylation (GO:0031065) | 3.41126527 |
| 97 | hormone catabolic process (GO:0042447) | 3.40243536 |
| 98 | regulation of telomere maintenance (GO:0032204) | 3.38888709 |
| 99 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.36214030 |
| 100 | phenol-containing compound catabolic process (GO:0019336) | 3.35090982 |
| 101 | formation of translation preinitiation complex (GO:0001731) | 3.34630981 |
| 102 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.32778589 |
| 103 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.31983755 |
| 104 | response to host immune response (GO:0052572) | 3.31983755 |
| 105 | intestinal epithelial cell development (GO:0060576) | 3.31502196 |
| 106 | negative T cell selection (GO:0043383) | 3.30941799 |
| 107 | germinal center formation (GO:0002467) | 3.30785880 |
| 108 | type I interferon signaling pathway (GO:0060337) | 3.30692840 |
| 109 | cellular response to type I interferon (GO:0071357) | 3.30692840 |
| 110 | mitotic chromosome condensation (GO:0007076) | 3.29041366 |
| 111 | DNA duplex unwinding (GO:0032508) | 3.28069830 |
| 112 | response to type I interferon (GO:0034340) | 3.27421751 |
| 113 | regulation of telomerase activity (GO:0051972) | 3.27250055 |
| 114 | neutrophil activation (GO:0042119) | 3.25992553 |
| 115 | response to dietary excess (GO:0002021) | 3.24484277 |
| 116 | T cell selection (GO:0045058) | 3.24470266 |
| 117 | ribosome biogenesis (GO:0042254) | 3.24042696 |
| 118 | DNA geometric change (GO:0032392) | 3.23969721 |
| 119 | maternal placenta development (GO:0001893) | 3.23215329 |
| 120 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.22262940 |
| 121 | negative regulation of interleukin-12 production (GO:0032695) | 3.21967131 |
| 122 | regulation of mast cell degranulation (GO:0043304) | 3.20634259 |
| 123 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.19835143 |
| 124 | response to host (GO:0075136) | 3.19835143 |
| 125 | response to host defenses (GO:0052200) | 3.19835143 |
| 126 | regulation of double-strand break repair (GO:2000779) | 3.18349780 |
| 127 | quinone metabolic process (GO:1901661) | 3.18021599 |
| 128 | granulocyte activation (GO:0036230) | 3.17744876 |
| 129 | response to interleukin-15 (GO:0070672) | 3.17596312 |
| 130 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 3.16662570 |
| 131 | regulation of T cell tolerance induction (GO:0002664) | 3.15671101 |
| 132 | pore complex assembly (GO:0046931) | 3.13788502 |
| 133 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 3.10196658 |
| 134 | cullin deneddylation (GO:0010388) | 3.08407782 |
| 135 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.07714644 |
| 136 | negative regulation of phagocytosis (GO:0050765) | 3.03312427 |
| 137 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.01580521 |
| 138 | positive regulation of type 2 immune response (GO:0002830) | 3.01345178 |
| 139 | DNA unwinding involved in DNA replication (GO:0006268) | 3.01005599 |
| 140 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.00093601 |
| 141 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.98583339 |
| 142 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.97682578 |
| 143 | B cell receptor signaling pathway (GO:0050853) | 2.97561256 |
| 144 | negative regulation of gene silencing (GO:0060969) | 2.97144518 |
| 145 | positive T cell selection (GO:0043368) | 2.95856560 |
| 146 | spindle assembly (GO:0051225) | 2.92902703 |
| 147 | apoptotic DNA fragmentation (GO:0006309) | 2.92255699 |
| 148 | detection of external biotic stimulus (GO:0098581) | 2.91848568 |
| 149 | regulation of DNA-dependent DNA replication (GO:0090329) | 2.90987373 |
| 150 | modulation by virus of host process (GO:0019054) | 2.90726215 |
| 151 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.89335438 |
| 152 | vitamin A metabolic process (GO:0006776) | 2.89104445 |
| 153 | GDP-mannose metabolic process (GO:0019673) | 2.87926998 |
| 154 | cellular response to interleukin-15 (GO:0071350) | 2.87615107 |
| 155 | myeloid cell activation involved in immune response (GO:0002275) | 2.87201096 |
| 156 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.86843204 |
| 157 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.86511997 |
| 158 | nucleoside transport (GO:0015858) | 2.85278293 |
| 159 | negative regulation of viral release from host cell (GO:1902187) | 2.85126826 |
| 160 | leukocyte degranulation (GO:0043299) | 2.84712261 |
| 161 | regulation of leukocyte degranulation (GO:0043300) | 2.82600564 |
| 162 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.81543393 |
| 163 | mitochondrion distribution (GO:0048311) | 2.81520477 |
| 164 | coenzyme catabolic process (GO:0009109) | 2.81087269 |
| 165 | pseudouridine synthesis (GO:0001522) | 2.80873048 |
| 166 | histone H3-K4 methylation (GO:0051568) | 2.78412748 |
| 167 | T cell migration (GO:0072678) | 2.78146504 |
| 168 | regulation of tolerance induction (GO:0002643) | 2.77305779 |
| 169 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 2.77016132 |
| 170 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.76693712 |
| 171 | tachykinin receptor signaling pathway (GO:0007217) | 2.76192278 |
| 172 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.74941340 |
| 173 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.74448408 |
| 174 | positive regulation of isotype switching (GO:0045830) | 2.73694514 |
| 175 | defense response to protozoan (GO:0042832) | 2.71974361 |
| 176 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.70309796 |
| 177 | negative regulation of innate immune response (GO:0045824) | 2.68909537 |
| 178 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.67361679 |
| 179 | cellular extravasation (GO:0045123) | 2.65962382 |
| 180 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.65594732 |
| 181 | negative regulation of T cell mediated immunity (GO:0002710) | 2.64831073 |
| 182 | modulation by symbiont of host cellular process (GO:0044068) | 2.64482130 |
| 183 | B cell mediated immunity (GO:0019724) | 2.62906206 |
| 184 | regulation of B cell differentiation (GO:0045577) | 2.61057182 |
| 185 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.60631496 |
| 186 | cellular response to virus (GO:0098586) | 2.60342015 |
| 187 | response to laminar fluid shear stress (GO:0034616) | 2.59969696 |
| 188 | positive regulation of B cell differentiation (GO:0045579) | 2.59487372 |
| 189 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.59297426 |
| 190 | response to protozoan (GO:0001562) | 2.55299742 |
| 191 | myeloid dendritic cell differentiation (GO:0043011) | 2.55250957 |
| 192 | negative regulation of interleukin-6 production (GO:0032715) | 2.55049352 |
| 193 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.54857778 |
| 194 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.54478047 |
| 195 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.54478047 |
| 196 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.54414164 |
| 197 | regulation of type 2 immune response (GO:0002828) | 2.54034974 |
| 198 | positive regulation of granulocyte differentiation (GO:0030854) | 2.53435947 |
| 199 | regulation of regulated secretory pathway (GO:1903305) | 2.53375738 |
| 200 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.52995815 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.48999945 |
| 2 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 5.47802876 |
| 3 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 5.47802876 |
| 4 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 5.47802876 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.32531328 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.49413973 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.02102496 |
| 8 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.91299265 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.79989901 |
| 10 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.79247292 |
| 11 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.73154520 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.70169790 |
| 13 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.65166428 |
| 14 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.59580723 |
| 15 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.52886070 |
| 16 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.41805928 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.32708106 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.26670937 |
| 19 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.24642840 |
| 20 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.22565523 |
| 21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.21923308 |
| 22 | MYC_22102868_ChIP-Seq_BL_Human | 2.18428146 |
| 23 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.17419809 |
| 24 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.16305608 |
| 25 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.15215625 |
| 26 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.14883814 |
| 27 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.14768956 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13682078 |
| 29 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.12463983 |
| 30 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10744586 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.09163787 |
| 32 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.99778816 |
| 33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.98916003 |
| 34 | MAF_26560356_Chip-Seq_TH2_Human | 1.93866334 |
| 35 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.91825469 |
| 36 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.91591147 |
| 37 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.91419314 |
| 38 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.91194254 |
| 39 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.86802391 |
| 40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.86475837 |
| 41 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.77901268 |
| 42 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.75714676 |
| 43 | MYB_26560356_Chip-Seq_TH2_Human | 1.75600546 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.75470725 |
| 45 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.74855816 |
| 46 | SPI1_23127762_ChIP-Seq_K562_Human | 1.74535922 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.73738598 |
| 48 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.72300003 |
| 49 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.71877971 |
| 50 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.69808951 |
| 51 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.67490782 |
| 52 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.67110378 |
| 53 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.66791780 |
| 54 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66312818 |
| 55 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.65053743 |
| 56 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.63306336 |
| 57 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.62073901 |
| 58 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.61781067 |
| 59 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.60280105 |
| 60 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.56403097 |
| 61 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.54358590 |
| 62 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.53827202 |
| 63 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53812123 |
| 64 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.51687478 |
| 65 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.51012000 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.49429242 |
| 67 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.47721336 |
| 68 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.46730320 |
| 69 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.46622670 |
| 70 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.46315385 |
| 71 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.43561284 |
| 72 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.39518425 |
| 73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.38699637 |
| 74 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.38253547 |
| 75 | * P68_20966046_ChIP-Seq_HELA_Human | 1.37897412 |
| 76 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.36843864 |
| 77 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.36144316 |
| 78 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.36031620 |
| 79 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.33709309 |
| 80 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.33677758 |
| 81 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.33649404 |
| 82 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.33092307 |
| 83 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32960566 |
| 84 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32584531 |
| 85 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.32410938 |
| 86 | GATA1_19941826_ChIP-Seq_K562_Human | 1.31226705 |
| 87 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.30758324 |
| 88 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.30554920 |
| 89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28612048 |
| 90 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28440911 |
| 91 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.28358540 |
| 92 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.27741141 |
| 93 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.26700859 |
| 94 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.25906396 |
| 95 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25254611 |
| 96 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.24157192 |
| 97 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23630116 |
| 98 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.22773832 |
| 99 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.22561897 |
| 100 | KDM2B_26808549_Chip-Seq_K562_Human | 1.22468260 |
| 101 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.22065644 |
| 102 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22033442 |
| 103 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21628146 |
| 104 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.20341717 |
| 105 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19522724 |
| 106 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18331413 |
| 107 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.17639770 |
| 108 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.17238008 |
| 109 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16468580 |
| 110 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.14074633 |
| 111 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.13527301 |
| 112 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13472079 |
| 113 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13373238 |
| 114 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.12231244 |
| 115 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.11616409 |
| 116 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.11373804 |
| 117 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11123370 |
| 118 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.09729318 |
| 119 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09133290 |
| 120 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09033051 |
| 121 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08234607 |
| 122 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.07934055 |
| 123 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.06676130 |
| 124 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.06622203 |
| 125 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.05805468 |
| 126 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.05282743 |
| 127 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.05183641 |
| 128 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.04330557 |
| 129 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02240592 |
| 130 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.00591781 |
| 131 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.99656604 |
| 132 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98448314 |
| 133 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.98356600 |
| 134 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.97362284 |
| 135 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.96397241 |
| 136 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.95922483 |
| 137 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.95087740 |
| 138 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95027494 |
| 139 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94870645 |
| 140 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94392808 |
| 141 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.93559179 |
| 142 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.92641957 |
| 143 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.92311929 |
| 144 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.91884250 |
| 145 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.91160000 |
| 146 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.88811622 |
| 147 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.87618974 |
| 148 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.87311865 |
| 149 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.84662406 |
| 150 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.84618421 |
| 151 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 0.83348789 |
| 152 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.82943843 |
| 153 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.82612264 |
| 154 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.82589891 |
| 155 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.82018918 |
| 156 | * XRN2_22483619_ChIP-Seq_HELA_Human | 0.81866121 |
| 157 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.81147964 |
| 158 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.79640230 |
| 159 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.79484228 |
| 160 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.78877551 |
| 161 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.78201963 |
| 162 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.78185943 |
| 163 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.78136686 |
| 164 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.77867592 |
| 165 | MAF_26560356_Chip-Seq_TH1_Human | 0.77112379 |
| 166 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76344606 |
| 167 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.76332309 |
| 168 | MYB_26560356_Chip-Seq_TH1_Human | 0.75998174 |
| 169 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.75384155 |
| 170 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.74781228 |
| 171 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.74694060 |
| 172 | UTX_26944678_Chip-Seq_JUKART_Human | 0.74285902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 3.99361588 |
| 2 | MP0004264_abnormal_extraembryonic_tissu | 3.99224438 |
| 3 | MP0003436_decreased_susceptibility_to | 3.89338854 |
| 4 | MP0003303_peritoneal_inflammation | 3.73824291 |
| 5 | MP0006292_abnormal_olfactory_placode | 3.62781509 |
| 6 | MP0002254_reproductive_system_inflammat | 3.58121618 |
| 7 | MP0003011_delayed_dark_adaptation | 3.52673071 |
| 8 | MP0003724_increased_susceptibility_to | 3.21340481 |
| 9 | MP0001835_abnormal_antigen_presentation | 3.13999876 |
| 10 | MP0004957_abnormal_blastocyst_morpholog | 3.12985245 |
| 11 | MP0003890_abnormal_embryonic-extraembry | 3.12951555 |
| 12 | MP0005075_abnormal_melanosome_morpholog | 3.03456489 |
| 13 | MP0005671_abnormal_response_to | 2.89553516 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.74199068 |
| 15 | MP0005387_immune_system_phenotype | 2.67725849 |
| 16 | MP0001790_abnormal_immune_system | 2.67725849 |
| 17 | MP0001800_abnormal_humoral_immune | 2.66516110 |
| 18 | MP0010352_gastrointestinal_tract_polyps | 2.60795385 |
| 19 | MP0005394_taste/olfaction_phenotype | 2.57926560 |
| 20 | MP0005499_abnormal_olfactory_system | 2.57926560 |
| 21 | MP0000685_abnormal_immune_system | 2.46589685 |
| 22 | MP0002332_abnormal_exercise_endurance | 2.43716874 |
| 23 | MP0005025_abnormal_response_to | 2.43678613 |
| 24 | MP0005451_abnormal_body_composition | 2.42228164 |
| 25 | MP0002419_abnormal_innate_immunity | 2.40701643 |
| 26 | MP0002653_abnormal_ependyma_morphology | 2.38212721 |
| 27 | MP0002723_abnormal_immune_serum | 2.37798885 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 2.37493472 |
| 29 | MP0004858_abnormal_nervous_system | 2.32571185 |
| 30 | MP0005464_abnormal_platelet_physiology | 2.31588763 |
| 31 | MP0009278_abnormal_bone_marrow | 2.29914238 |
| 32 | MP0002452_abnormal_antigen_presenting | 2.28085570 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 2.26868214 |
| 34 | MP0002420_abnormal_adaptive_immunity | 2.26693804 |
| 35 | MP0001819_abnormal_immune_cell | 2.24586959 |
| 36 | MP0009785_altered_susceptibility_to | 2.24257292 |
| 37 | MP0003122_maternal_imprinting | 2.19039348 |
| 38 | MP0008260_abnormal_autophagy | 2.09027598 |
| 39 | MP0003077_abnormal_cell_cycle | 2.07648273 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 2.03545222 |
| 41 | MP0004947_skin_inflammation | 2.01736396 |
| 42 | MP0003121_genomic_imprinting | 1.93445915 |
| 43 | MP0004510_myositis | 1.92756419 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.91636258 |
| 45 | * MP0001672_abnormal_embryogenesis/_devel | 1.90134339 |
| 46 | * MP0005380_embryogenesis_phenotype | 1.90134339 |
| 47 | MP0003111_abnormal_nucleus_morphology | 1.88796968 |
| 48 | MP0002877_abnormal_melanocyte_morpholog | 1.86643547 |
| 49 | MP0000716_abnormal_immune_system | 1.86462759 |
| 50 | MP0005257_abnormal_intraocular_pressure | 1.86360575 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.86342482 |
| 52 | MP0000678_abnormal_parathyroid_gland | 1.82928425 |
| 53 | MP0002396_abnormal_hematopoietic_system | 1.81954416 |
| 54 | * MP0002088_abnormal_embryonic_growth/wei | 1.76129544 |
| 55 | MP0006082_CNS_inflammation | 1.75884840 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.75169301 |
| 57 | * MP0003984_embryonic_growth_retardation | 1.74973272 |
| 58 | MP0010094_abnormal_chromosome_stability | 1.73737208 |
| 59 | MP0010155_abnormal_intestine_physiology | 1.73104622 |
| 60 | MP0005058_abnormal_lysosome_morphology | 1.69000529 |
| 61 | MP0001873_stomach_inflammation | 1.68256150 |
| 62 | * MP0000350_abnormal_cell_proliferation | 1.65951628 |
| 63 | MP0008961_abnormal_basal_metabolism | 1.63171208 |
| 64 | MP0006035_abnormal_mitochondrial_morpho | 1.62682983 |
| 65 | MP0010030_abnormal_orbit_morphology | 1.60035262 |
| 66 | MP0002086_abnormal_extraembryonic_tissu | 1.56145872 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 1.55335252 |
| 68 | MP0001849_ear_inflammation | 1.53177731 |
| 69 | MP0001293_anophthalmia | 1.51925263 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 1.45829885 |
| 71 | MP0003938_abnormal_ear_development | 1.45749744 |
| 72 | MP0002127_abnormal_cardiovascular_syste | 1.45268227 |
| 73 | MP0002085_abnormal_embryonic_tissue | 1.43803194 |
| 74 | MP0001845_abnormal_inflammatory_respons | 1.43578055 |
| 75 | MP0000490_abnormal_crypts_of | 1.42517197 |
| 76 | MP0003183_abnormal_peptide_metabolism | 1.35195743 |
| 77 | MP0005310_abnormal_salivary_gland | 1.33862965 |
| 78 | MP0003693_abnormal_embryo_hatching | 1.31695473 |
| 79 | MP0002084_abnormal_developmental_patter | 1.29584216 |
| 80 | MP0008007_abnormal_cellular_replicative | 1.28286837 |
| 81 | MP0003866_abnormal_defecation | 1.27373559 |
| 82 | MP0002092_abnormal_eye_morphology | 1.25868362 |
| 83 | MP0008004_abnormal_stomach_pH | 1.25257444 |
| 84 | MP0002932_abnormal_joint_morphology | 1.24926013 |
| 85 | MP0000465_gastrointestinal_hemorrhage | 1.24911251 |
| 86 | MP0003123_paternal_imprinting | 1.24713773 |
| 87 | MP0001730_embryonic_growth_arrest | 1.24517887 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 1.21510523 |
| 89 | MP0008469_abnormal_protein_level | 1.21101015 |
| 90 | MP0001853_heart_inflammation | 1.20528915 |
| 91 | MP0000313_abnormal_cell_death | 1.19516389 |
| 92 | MP0002998_abnormal_bone_remodeling | 1.18073829 |
| 93 | MP0001697_abnormal_embryo_size | 1.17081290 |
| 94 | MP0004808_abnormal_hematopoietic_stem | 1.15187308 |
| 95 | MP0005266_abnormal_metabolism | 1.14533848 |
| 96 | MP0002166_altered_tumor_susceptibility | 1.13857674 |
| 97 | MP0001851_eye_inflammation | 1.12231574 |
| 98 | MP0002138_abnormal_hepatobiliary_system | 1.11192651 |
| 99 | MP0002132_abnormal_respiratory_system | 1.11171461 |
| 100 | MP0004133_heterotaxia | 1.11000806 |
| 101 | MP0000049_abnormal_middle_ear | 1.10998448 |
| 102 | MP0003075_altered_response_to | 1.09791910 |
| 103 | MP0003119_abnormal_digestive_system | 1.07290980 |
| 104 | MP0008932_abnormal_embryonic_tissue | 1.05976118 |
| 105 | MP0009840_abnormal_foam_cell | 1.05190577 |
| 106 | MP0008789_abnormal_olfactory_epithelium | 1.01802990 |
| 107 | MP0002970_abnormal_white_adipose | 1.01672580 |
| 108 | * MP0002080_prenatal_lethality | 1.01018995 |
| 109 | MP0009764_decreased_sensitivity_to | 0.99695723 |
| 110 | MP0001348_abnormal_lacrimal_gland | 0.99273528 |
| 111 | MP0003453_abnormal_keratinocyte_physiol | 0.98078639 |
| 112 | MP0002925_abnormal_cardiovascular_devel | 0.97083121 |
| 113 | MP0000762_abnormal_tongue_morphology | 0.96968410 |
| 114 | MP0008770_decreased_survivor_rate | 0.96450372 |
| 115 | MP0000432_abnormal_head_morphology | 0.95822629 |
| 116 | * MP0004197_abnormal_fetal_growth/weight/ | 0.95684158 |
| 117 | MP0005166_decreased_susceptibility_to | 0.94506873 |
| 118 | MP0005023_abnormal_wound_healing | 0.94058868 |
| 119 | MP0002019_abnormal_tumor_incidence | 0.93771996 |
| 120 | MP0002114_abnormal_axial_skeleton | 0.93700058 |
| 121 | MP0000428_abnormal_craniofacial_morphol | 0.92373490 |
| 122 | MP0002722_abnormal_immune_system | 0.92055468 |
| 123 | MP0003935_abnormal_craniofacial_develop | 0.91432345 |
| 124 | MP0000689_abnormal_spleen_morphology | 0.91328248 |
| 125 | MP0003828_pulmonary_edema | 0.90617648 |
| 126 | MP0002933_joint_inflammation | 0.89583069 |
| 127 | MP0001663_abnormal_digestive_system | 0.88876069 |
| 128 | MP0003448_altered_tumor_morphology | 0.86622591 |
| 129 | MP0000858_altered_metastatic_potential | 0.85850895 |
| 130 | MP0003091_abnormal_cell_migration | 0.85714131 |
| 131 | MP0005390_skeleton_phenotype | 0.85200169 |
| 132 | MP0002405_respiratory_system_inflammati | 0.83686778 |
| 133 | MP0003786_premature_aging | 0.83369730 |
| 134 | MP0005083_abnormal_biliary_tract | 0.83131343 |
| 135 | MP0002398_abnormal_bone_marrow | 0.81242317 |
| 136 | MP0000703_abnormal_thymus_morphology | 0.80046937 |
| 137 | MP0004883_abnormal_blood_vessel | 0.79906923 |
| 138 | MP0000750_abnormal_muscle_regeneration | 0.79054823 |
| 139 | MP0005076_abnormal_cell_differentiation | 0.78968181 |
| 140 | MP0003755_abnormal_palate_morphology | 0.78737099 |
| 141 | MP0002233_abnormal_nose_morphology | 0.78126348 |
| 142 | MP0008058_abnormal_DNA_repair | 0.77907846 |
| 143 | MP0000343_altered_response_to | 0.77633617 |
| 144 | MP0009703_decreased_birth_body | 0.77561368 |
| 145 | MP0003566_abnormal_cell_adhesion | 0.76859751 |
| 146 | MP0003283_abnormal_digestive_organ | 0.76108911 |
| 147 | MP0005666_abnormal_adipose_tissue | 0.74531664 |
| 148 | MP0005248_abnormal_Harderian_gland | 0.74160128 |
| 149 | MP0005508_abnormal_skeleton_morphology | 0.73428459 |
| 150 | MP0003787_abnormal_imprinting | 0.73229746 |
| 151 | MP0005391_vision/eye_phenotype | 0.71463723 |
| 152 | MP0002009_preneoplasia | 0.71406472 |
| 153 | MP0002429_abnormal_blood_cell | 0.70999393 |
| 154 | MP0004381_abnormal_hair_follicle | 0.70384632 |
| 155 | MP0009115_abnormal_fat_cell | 0.70273012 |
| 156 | MP0000249_abnormal_blood_vessel | 0.69972443 |
| 157 | MP0003045_fibrosis | 0.69911972 |
| 158 | MP0004185_abnormal_adipocyte_glucose | 0.69552888 |
| 159 | MP0002269_muscular_atrophy | 0.69339903 |
| 160 | MP0009763_increased_sensitivity_to | 0.68920541 |
| 161 | MP0003763_abnormal_thymus_physiology | 0.68334826 |
| 162 | MP0003795_abnormal_bone_structure | 0.67954345 |
| 163 | MP0002006_tumorigenesis | 0.67028788 |
| 164 | MP0001545_abnormal_hematopoietic_system | 0.66590407 |
| 165 | MP0005397_hematopoietic_system_phenotyp | 0.66590407 |
| 166 | MP0001286_abnormal_eye_development | 0.66271230 |
| 167 | MP0002116_abnormal_craniofacial_bone | 0.65427955 |
| 168 | MP0002249_abnormal_larynx_morphology | 0.64777490 |
| 169 | MP0003137_abnormal_impulse_conducting | 0.64524066 |
| 170 | MP0005621_abnormal_cell_physiology | 0.63833518 |
| 171 | MP0005381_digestive/alimentary_phenotyp | 0.63607409 |
| 172 | MP0000015_abnormal_ear_pigmentation | 0.62998507 |
| 173 | MP0000609_abnormal_liver_physiology | 0.61518075 |
| 174 | MP0005375_adipose_tissue_phenotype | 0.60707481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 6.74336931 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 6.14060301 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.05197848 |
| 4 | Rib fusion (HP:0000902) | 4.90631023 |
| 5 | Hepatoblastoma (HP:0002884) | 4.82910559 |
| 6 | Multiple enchondromatosis (HP:0005701) | 4.81583572 |
| 7 | Abnormality of the lower motor neuron (HP:0002366) | 4.41338069 |
| 8 | Ependymoma (HP:0002888) | 4.38234756 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.10347498 |
| 10 | Stomatitis (HP:0010280) | 3.89303566 |
| 11 | Myositis (HP:0100614) | 3.85105929 |
| 12 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.84518594 |
| 13 | Neoplasm of striated muscle (HP:0009728) | 3.81828647 |
| 14 | Prolonged bleeding time (HP:0003010) | 3.77637565 |
| 15 | Recurrent abscess formation (HP:0002722) | 3.73508056 |
| 16 | Rhabdomyosarcoma (HP:0002859) | 3.67914052 |
| 17 | Orchitis (HP:0100796) | 3.65416175 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.64527216 |
| 19 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.62232572 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.57007560 |
| 21 | Increased IgE level (HP:0003212) | 3.53058200 |
| 22 | Meningitis (HP:0001287) | 3.46190080 |
| 23 | Obstructive lung disease (HP:0006536) | 3.42483928 |
| 24 | Chronic obstructive pulmonary disease (HP:0006510) | 3.42483928 |
| 25 | Rectal fistula (HP:0100590) | 3.42071550 |
| 26 | Rectovaginal fistula (HP:0000143) | 3.42071550 |
| 27 | Petechiae (HP:0000967) | 3.41920158 |
| 28 | Chromsome breakage (HP:0040012) | 3.37615456 |
| 29 | Optic neuritis (HP:0100653) | 3.37174153 |
| 30 | Retrobulbar optic neuritis (HP:0100654) | 3.37174153 |
| 31 | Embryonal renal neoplasm (HP:0011794) | 3.34418679 |
| 32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.33467463 |
| 33 | Mediastinal lymphadenopathy (HP:0100721) | 3.30406356 |
| 34 | Intestinal fistula (HP:0100819) | 3.28414198 |
| 35 | Cellulitis (HP:0100658) | 3.21256985 |
| 36 | Recurrent fungal infections (HP:0002841) | 3.21227109 |
| 37 | Testicular atrophy (HP:0000029) | 3.14893378 |
| 38 | Fused cervical vertebrae (HP:0002949) | 3.11659462 |
| 39 | Hypochromic anemia (HP:0001931) | 3.10548472 |
| 40 | Abnormality of the astrocytes (HP:0100707) | 3.06905066 |
| 41 | Astrocytoma (HP:0009592) | 3.06905066 |
| 42 | Gastrointestinal infarctions (HP:0005244) | 3.03550367 |
| 43 | Spontaneous hematomas (HP:0007420) | 2.98590151 |
| 44 | Hypoplasia of the fovea (HP:0007750) | 2.98031348 |
| 45 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.98031348 |
| 46 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.97025150 |
| 47 | Chest pain (HP:0100749) | 2.95053761 |
| 48 | Epistaxis (HP:0000421) | 2.93784864 |
| 49 | Short humerus (HP:0005792) | 2.92257688 |
| 50 | Vaginal fistula (HP:0004320) | 2.91555794 |
| 51 | Vasculitis (HP:0002633) | 2.90204192 |
| 52 | Pulmonary infiltrates (HP:0002113) | 2.85919320 |
| 53 | Abnormality of the salivary glands (HP:0010286) | 2.85515345 |
| 54 | Partial duplication of thumb phalanx (HP:0009944) | 2.85311792 |
| 55 | Trismus (HP:0000211) | 2.81832085 |
| 56 | Gingivitis (HP:0000230) | 2.81580560 |
| 57 | Abnormal lung lobation (HP:0002101) | 2.77528624 |
| 58 | Purpura (HP:0000979) | 2.77408003 |
| 59 | Amyotrophic lateral sclerosis (HP:0007354) | 2.75201477 |
| 60 | Obstructive sleep apnea (HP:0002870) | 2.72959694 |
| 61 | Increased IgM level (HP:0003496) | 2.72304057 |
| 62 | Abnormality of the fingertips (HP:0001211) | 2.71768066 |
| 63 | Encephalitis (HP:0002383) | 2.71520329 |
| 64 | Pustule (HP:0200039) | 2.67541213 |
| 65 | Ragged-red muscle fibers (HP:0003200) | 2.63149951 |
| 66 | Meckel diverticulum (HP:0002245) | 2.62674236 |
| 67 | Gastrointestinal inflammation (HP:0004386) | 2.62617275 |
| 68 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.62345047 |
| 69 | Recurrent viral infections (HP:0004429) | 2.61826046 |
| 70 | Preauricular skin tag (HP:0000384) | 2.58787718 |
| 71 | Keratoconjunctivitis sicca (HP:0001097) | 2.58122557 |
| 72 | Abnormality of the ileum (HP:0001549) | 2.56142392 |
| 73 | Agammaglobulinemia (HP:0004432) | 2.55574447 |
| 74 | Gastrointestinal stroma tumor (HP:0100723) | 2.52299431 |
| 75 | Impulsivity (HP:0100710) | 2.52237217 |
| 76 | Urticaria (HP:0001025) | 2.51889052 |
| 77 | Gingival bleeding (HP:0000225) | 2.51339377 |
| 78 | Partial duplication of the phalanx of hand (HP:0009999) | 2.50161758 |
| 79 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.50069849 |
| 80 | Abnormality of chromosome segregation (HP:0002916) | 2.46598124 |
| 81 | Combined immunodeficiency (HP:0005387) | 2.45546182 |
| 82 | Inflammation of the large intestine (HP:0002037) | 2.44737659 |
| 83 | Short 5th finger (HP:0009237) | 2.44732497 |
| 84 | Shawl scrotum (HP:0000049) | 2.43170578 |
| 85 | Large earlobe (HP:0009748) | 2.42689979 |
| 86 | Recurrent skin infections (HP:0001581) | 2.42226999 |
| 87 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.41887443 |
| 88 | Abnormal platelet volume (HP:0011876) | 2.41866974 |
| 89 | Anomalous pulmonary venous return (HP:0010772) | 2.41565900 |
| 90 | Tongue fasciculations (HP:0001308) | 2.40303946 |
| 91 | Skin tags (HP:0010609) | 2.39180054 |
| 92 | Horizontal nystagmus (HP:0000666) | 2.37529115 |
| 93 | Bifid tongue (HP:0010297) | 2.36888226 |
| 94 | Reduced antithrombin III activity (HP:0001976) | 2.33422032 |
| 95 | Increased serum ferritin (HP:0003281) | 2.32877541 |
| 96 | Panhypogammaglobulinemia (HP:0003139) | 2.32010467 |
| 97 | Arterial thrombosis (HP:0004420) | 2.31400627 |
| 98 | Keratoconjunctivitis (HP:0001096) | 2.28676570 |
| 99 | Supernumerary spleens (HP:0009799) | 2.28135764 |
| 100 | Abnormality of T cells (HP:0002843) | 2.28061826 |
| 101 | Granulocytopenia (HP:0001913) | 2.27848117 |
| 102 | Glioma (HP:0009733) | 2.27642780 |
| 103 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.27248482 |
| 104 | Hypertensive crisis (HP:0100735) | 2.27113475 |
| 105 | Abnormal cartilage morphology (HP:0002763) | 2.26468776 |
| 106 | Recurrent cutaneous fungal infections (HP:0011370) | 2.24896557 |
| 107 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.24896557 |
| 108 | Generalized hypotonia (HP:0001290) | 2.23495848 |
| 109 | Polycythemia (HP:0001901) | 2.22405951 |
| 110 | Osteomyelitis (HP:0002754) | 2.22296441 |
| 111 | Emphysema (HP:0002097) | 2.22150805 |
| 112 | Preauricular pit (HP:0004467) | 2.21447318 |
| 113 | Periauricular skin pits (HP:0100277) | 2.21447318 |
| 114 | Episodic fever (HP:0001954) | 2.21386655 |
| 115 | Abnormality of T cell physiology (HP:0011840) | 2.21271520 |
| 116 | Muscle fibrillation (HP:0010546) | 2.21269693 |
| 117 | Lymphopenia (HP:0001888) | 2.19852724 |
| 118 | Abnormality of the fovea (HP:0000493) | 2.19386708 |
| 119 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 2.19134411 |
| 120 | Nasal polyposis (HP:0100582) | 2.17964746 |
| 121 | Cheilitis (HP:0100825) | 2.17053082 |
| 122 | Sepsis (HP:0100806) | 2.16729494 |
| 123 | Dysostosis multiplex (HP:0000943) | 2.16611653 |
| 124 | Restrictive lung disease (HP:0002091) | 2.14867524 |
| 125 | Hepatosplenomegaly (HP:0001433) | 2.14718929 |
| 126 | Duodenal stenosis (HP:0100867) | 2.12442497 |
| 127 | Small intestinal stenosis (HP:0012848) | 2.12442497 |
| 128 | T lymphocytopenia (HP:0005403) | 2.11656325 |
| 129 | Progressive muscle weakness (HP:0003323) | 2.11342892 |
| 130 | Pseudobulbar signs (HP:0002200) | 2.11155744 |
| 131 | Peripheral hypomyelination (HP:0007182) | 2.10933018 |
| 132 | Vertebral fusion (HP:0002948) | 2.10503800 |
| 133 | Papilloma (HP:0012740) | 2.10096945 |
| 134 | Verrucae (HP:0200043) | 2.10096945 |
| 135 | Hemoptysis (HP:0002105) | 2.09788880 |
| 136 | Slow saccadic eye movements (HP:0000514) | 2.08967611 |
| 137 | Alveolar cell carcinoma (HP:0006519) | 2.08516267 |
| 138 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.07951986 |
| 139 | Broad face (HP:0000283) | 2.07609745 |
| 140 | Hypergammaglobulinemia (HP:0010702) | 2.07586725 |
| 141 | Leukocytosis (HP:0001974) | 2.07248917 |
| 142 | Medulloblastoma (HP:0002885) | 2.06767066 |
| 143 | Abnormality of the musculature of the hand (HP:0001421) | 2.06716056 |
| 144 | Increased connective tissue (HP:0009025) | 2.06214946 |
| 145 | Colitis (HP:0002583) | 2.06143847 |
| 146 | Neoplasm of the heart (HP:0100544) | 2.05888004 |
| 147 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.05132777 |
| 148 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.04570736 |
| 149 | Abnormality of the pulmonary veins (HP:0011718) | 2.03846153 |
| 150 | Pendular nystagmus (HP:0012043) | 2.03698947 |
| 151 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.03167299 |
| 152 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.02115371 |
| 153 | Fatigue (HP:0012378) | 2.01947548 |
| 154 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.01010283 |
| 155 | Increased cerebral lipofuscin (HP:0011813) | 2.00853832 |
| 156 | Loss of speech (HP:0002371) | 1.99963613 |
| 157 | Villous atrophy (HP:0011473) | 1.99414539 |
| 158 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.99414539 |
| 159 | Anorexia (HP:0002039) | 1.98817495 |
| 160 | Difficulty running (HP:0009046) | 1.98616777 |
| 161 | Menorrhagia (HP:0000132) | 1.98131418 |
| 162 | Joint swelling (HP:0001386) | 1.97671569 |
| 163 | Malignant neoplasm of the central nervous system (HP:0100836) | 1.94831796 |
| 164 | Easy fatigability (HP:0003388) | 1.94762667 |
| 165 | Abnormality of iron homeostasis (HP:0011031) | 1.94717496 |
| 166 | Renal duplication (HP:0000075) | 1.93985758 |
| 167 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.93023376 |
| 168 | Selective tooth agenesis (HP:0001592) | 1.91385306 |
| 169 | Hand muscle atrophy (HP:0009130) | 1.91113642 |
| 170 | Glossoptosis (HP:0000162) | 1.91050132 |
| 171 | Abnormality of T cell number (HP:0011839) | 1.90781967 |
| 172 | Supernumerary ribs (HP:0005815) | 1.90638423 |
| 173 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.90410103 |
| 174 | Abnormality of the pleura (HP:0002103) | 1.89807549 |
| 175 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.89316983 |
| 176 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.89316983 |
| 177 | Abnormality of glycolipid metabolism (HP:0010969) | 1.89316983 |
| 178 | Hypertriglyceridemia (HP:0002155) | 1.87171754 |
| 179 | Myelodysplasia (HP:0002863) | 1.86394722 |
| 180 | Abnormality of the pubic bones (HP:0003172) | 1.86092707 |
| 181 | Cholecystitis (HP:0001082) | 1.85136357 |
| 182 | Abnormal gallbladder physiology (HP:0012438) | 1.85136357 |
| 183 | Progressive neurologic deterioration (HP:0002344) | 1.85035093 |
| 184 | Abnormality of the columella (HP:0009929) | 1.84675801 |
| 185 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.84591516 |
| 186 | Nasolacrimal duct obstruction (HP:0000579) | 1.84569783 |
| 187 | Premature ovarian failure (HP:0008209) | 1.84354387 |
| 188 | Fasciculations (HP:0002380) | 1.84103521 |
| 189 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.83697869 |
| 190 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.83063300 |
| 191 | Skin pits (HP:0100276) | 1.82007959 |
| 192 | Spinal muscular atrophy (HP:0007269) | 1.81448955 |
| 193 | Abnormality of the nasal mucosa (HP:0000433) | 1.81327689 |
| 194 | Upper motor neuron abnormality (HP:0002127) | 1.80639828 |
| 195 | Hypopigmentation of the fundus (HP:0007894) | 1.79990315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 8.50569230 |
| 2 | ERN1 | 4.56490393 |
| 3 | GRK5 | 4.32405472 |
| 4 | GRK6 | 4.09452078 |
| 5 | RIPK4 | 3.32288579 |
| 6 | CSF1R | 2.74099191 |
| 7 | STK10 | 2.73969463 |
| 8 | TGFBR2 | 2.59397240 |
| 9 | ADRBK2 | 2.57425545 |
| 10 | GRK1 | 2.57386018 |
| 11 | TYRO3 | 2.56558324 |
| 12 | TTK | 2.49994738 |
| 13 | MAP2K3 | 2.44960897 |
| 14 | SIK3 | 2.35861799 |
| 15 | MATK | 2.25040145 |
| 16 | MAP3K10 | 2.20911113 |
| 17 | MAPK7 | 2.20283081 |
| 18 | GRK7 | 2.13148366 |
| 19 | IRAK4 | 2.12733683 |
| 20 | TYK2 | 1.99606676 |
| 21 | SMG1 | 1.98945433 |
| 22 | MAP3K3 | 1.89695985 |
| 23 | EPHB1 | 1.86202330 |
| 24 | IRAK3 | 1.85229383 |
| 25 | CDK7 | 1.83361454 |
| 26 | TNK2 | 1.80126430 |
| 27 | MOS | 1.72505224 |
| 28 | MAP3K11 | 1.72061479 |
| 29 | TXK | 1.58491891 |
| 30 | WNK1 | 1.57269161 |
| 31 | MAP3K14 | 1.51412090 |
| 32 | JAK3 | 1.44854392 |
| 33 | TBK1 | 1.44645755 |
| 34 | IKBKE | 1.41528917 |
| 35 | BTK | 1.38715068 |
| 36 | PAK4 | 1.35832629 |
| 37 | CHEK2 | 1.35190671 |
| 38 | FES | 1.33884218 |
| 39 | HIPK2 | 1.33544919 |
| 40 | PRKG2 | 1.31199351 |
| 41 | CAMK4 | 1.30520319 |
| 42 | MAP3K1 | 1.27796678 |
| 43 | PLK1 | 1.19066340 |
| 44 | EPHA2 | 1.16755819 |
| 45 | MARK2 | 1.14918357 |
| 46 | TESK1 | 1.13460194 |
| 47 | SYK | 1.11722914 |
| 48 | CDC7 | 1.08915717 |
| 49 | CSK | 1.08403431 |
| 50 | FGFR3 | 1.02938641 |
| 51 | MAP3K13 | 1.02279694 |
| 52 | MARK3 | 1.02054025 |
| 53 | NEK2 | 1.01810018 |
| 54 | IRAK2 | 1.00879218 |
| 55 | CDC42BPA | 0.98759359 |
| 56 | AKT3 | 0.97424221 |
| 57 | FGFR4 | 0.95776290 |
| 58 | CHEK1 | 0.87150740 |
| 59 | ALK | 0.86840962 |
| 60 | JAK1 | 0.85297185 |
| 61 | KSR2 | 0.84941037 |
| 62 | NTRK1 | 0.82943344 |
| 63 | CAMK1D | 0.82560928 |
| 64 | LYN | 0.82012647 |
| 65 | MAP4K1 | 0.80701793 |
| 66 | IRAK1 | 0.77715629 |
| 67 | PTK6 | 0.77678198 |
| 68 | PDPK1 | 0.77604333 |
| 69 | LRRK2 | 0.76745372 |
| 70 | PDK1 | 0.76690498 |
| 71 | ICK | 0.76114211 |
| 72 | JAK2 | 0.75967246 |
| 73 | ADRBK1 | 0.75926903 |
| 74 | CDK4 | 0.75102366 |
| 75 | LCK | 0.73530176 |
| 76 | BUB1 | 0.69735709 |
| 77 | MAP3K5 | 0.69590099 |
| 78 | MTOR | 0.68562219 |
| 79 | AKT2 | 0.67295687 |
| 80 | FGR | 0.65809383 |
| 81 | RPS6KC1 | 0.63304080 |
| 82 | RPS6KL1 | 0.63304080 |
| 83 | PRKD3 | 0.63018121 |
| 84 | IKBKB | 0.61986305 |
| 85 | TTN | 0.61426260 |
| 86 | CDK2 | 0.58508214 |
| 87 | RPS6KB2 | 0.58493103 |
| 88 | PRKD2 | 0.57525990 |
| 89 | NME2 | 0.56896127 |
| 90 | MAP2K6 | 0.56652417 |
| 91 | WEE1 | 0.56360024 |
| 92 | STK4 | 0.55098901 |
| 93 | EIF2AK2 | 0.55093820 |
| 94 | MAPK12 | 0.54492605 |
| 95 | ITK | 0.53863210 |
| 96 | PIM1 | 0.53506326 |
| 97 | BLK | 0.52686867 |
| 98 | BMX | 0.52365403 |
| 99 | TAOK3 | 0.50930454 |
| 100 | MAP3K7 | 0.50874830 |
| 101 | AURKB | 0.49225971 |
| 102 | DYRK3 | 0.48922615 |
| 103 | RPS6KA2 | 0.47839375 |
| 104 | MAPK11 | 0.47028768 |
| 105 | AURKA | 0.45454142 |
| 106 | ATM | 0.44781292 |
| 107 | RPS6KA6 | 0.44577115 |
| 108 | TESK2 | 0.44404808 |
| 109 | CHUK | 0.43993596 |
| 110 | LATS2 | 0.43340539 |
| 111 | STK38 | 0.43265126 |
| 112 | ARAF | 0.42119003 |
| 113 | PDGFRA | 0.41686326 |
| 114 | MAP2K4 | 0.40587633 |
| 115 | PKN2 | 0.39585710 |
| 116 | MAP3K6 | 0.38656361 |
| 117 | MAP2K2 | 0.38428185 |
| 118 | TAOK1 | 0.37980197 |
| 119 | DYRK1B | 0.36969798 |
| 120 | SGK3 | 0.36949778 |
| 121 | PIM2 | 0.36696888 |
| 122 | TEC | 0.36281766 |
| 123 | FYN | 0.36224137 |
| 124 | SIK2 | 0.36199122 |
| 125 | TAOK2 | 0.35475547 |
| 126 | CDK9 | 0.35370877 |
| 127 | PAK1 | 0.34674661 |
| 128 | BRD4 | 0.33712473 |
| 129 | PRKCI | 0.33562891 |
| 130 | MAP3K8 | 0.32438243 |
| 131 | PTK2 | 0.32054586 |
| 132 | DDR2 | 0.31702387 |
| 133 | MAPK1 | 0.30228665 |
| 134 | CDK1 | 0.29631614 |
| 135 | ATR | 0.28827933 |
| 136 | PRPF4B | 0.28617770 |
| 137 | PRKCD | 0.27876632 |
| 138 | MAPKAPK2 | 0.25341853 |
| 139 | TRIB3 | 0.25243032 |
| 140 | MAPK10 | 0.24652020 |
| 141 | MAPK14 | 0.24470534 |
| 142 | MAPKAPK3 | 0.24249087 |
| 143 | NEK1 | 0.22784045 |
| 144 | IGF1R | 0.21577635 |
| 145 | ERBB2 | 0.20577600 |
| 146 | ZAP70 | 0.20548384 |
| 147 | MAPK4 | 0.20405629 |
| 148 | GSK3B | 0.20212304 |
| 149 | CDK8 | 0.19164293 |
| 150 | CSNK1E | 0.19123665 |
| 151 | PRKAA1 | 0.18948668 |
| 152 | INSR | 0.18688329 |
| 153 | GSK3A | 0.17934247 |
| 154 | CDK6 | 0.17933348 |
| 155 | RIPK1 | 0.17059314 |
| 156 | HCK | 0.16618046 |
| 157 | SIK1 | 0.15884975 |
| 158 | YES1 | 0.15384151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 4.85952304 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.62082373 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.90540705 |
| 4 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.92440518 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.57847607 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 2.50051550 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.15631315 |
| 8 | RNA transport_Homo sapiens_hsa03013 | 2.12218888 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.08660260 |
| 10 | Galactose metabolism_Homo sapiens_hsa00052 | 2.07160934 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 1.92667853 |
| 12 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.90231002 |
| 13 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.86563707 |
| 14 | Cell cycle_Homo sapiens_hsa04110 | 1.86379170 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.86336365 |
| 16 | Base excision repair_Homo sapiens_hsa03410 | 1.84526381 |
| 17 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.81397295 |
| 18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.71144958 |
| 19 | Thyroid cancer_Homo sapiens_hsa05216 | 1.71022781 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.68678322 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.68145367 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.68006485 |
| 23 | Homologous recombination_Homo sapiens_hsa03440 | 1.65309890 |
| 24 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.63373147 |
| 25 | Spliceosome_Homo sapiens_hsa03040 | 1.59052145 |
| 26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.52951947 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.52564552 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.49390217 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.47927854 |
| 30 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.41163427 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.40276902 |
| 32 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.39705961 |
| 33 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.37916497 |
| 34 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.37802694 |
| 35 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.36706863 |
| 36 | RNA degradation_Homo sapiens_hsa03018 | 1.34257755 |
| 37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.31662636 |
| 38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.30685794 |
| 39 | Ribosome_Homo sapiens_hsa03010 | 1.30374200 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 1.29778312 |
| 41 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.27291764 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.27103436 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 1.24605311 |
| 44 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.23467617 |
| 45 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.22672058 |
| 46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.19716691 |
| 47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.18876033 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.18115171 |
| 49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.17766031 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.17232621 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.14909865 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.09798079 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 1.09782780 |
| 54 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.09215145 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 1.07571217 |
| 56 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.07171461 |
| 57 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.06867806 |
| 58 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.06531805 |
| 59 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.00535181 |
| 60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.00306112 |
| 61 | Other glycan degradation_Homo sapiens_hsa00511 | 0.98395020 |
| 62 | Endocytosis_Homo sapiens_hsa04144 | 0.97291386 |
| 63 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.96907264 |
| 64 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.96194399 |
| 65 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.92659244 |
| 66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.91568413 |
| 67 | Endometrial cancer_Homo sapiens_hsa05213 | 0.91023290 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.87913166 |
| 69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87090018 |
| 70 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.86440920 |
| 71 | Pathways in cancer_Homo sapiens_hsa05200 | 0.85083881 |
| 72 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.84885751 |
| 73 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.84719894 |
| 74 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.84401078 |
| 75 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.84294146 |
| 76 | Apoptosis_Homo sapiens_hsa04210 | 0.82745036 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.82540176 |
| 78 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.82358153 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80221169 |
| 80 | Phagosome_Homo sapiens_hsa04145 | 0.78217115 |
| 81 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78169720 |
| 82 | Bladder cancer_Homo sapiens_hsa05219 | 0.77702830 |
| 83 | Prostate cancer_Homo sapiens_hsa05215 | 0.77428974 |
| 84 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.77371538 |
| 85 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.76758943 |
| 86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.75758555 |
| 87 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.75655206 |
| 88 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74946131 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74504026 |
| 90 | Asthma_Homo sapiens_hsa05310 | 0.73692931 |
| 91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.73119913 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71145585 |
| 93 | Lysosome_Homo sapiens_hsa04142 | 0.71015427 |
| 94 | RNA polymerase_Homo sapiens_hsa03020 | 0.70461158 |
| 95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69652859 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.69624784 |
| 97 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.69152763 |
| 98 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.68971475 |
| 99 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68642746 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.68363874 |
| 101 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68108149 |
| 102 | Leishmaniasis_Homo sapiens_hsa05140 | 0.68037434 |
| 103 | Basal transcription factors_Homo sapiens_hsa03022 | 0.67563207 |
| 104 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.67367798 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66829461 |
| 106 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.66771933 |
| 107 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.66501902 |
| 108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65154164 |
| 109 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.64730928 |
| 110 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64532671 |
| 111 | Sulfur relay system_Homo sapiens_hsa04122 | 0.64221864 |
| 112 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62691009 |
| 113 | Adherens junction_Homo sapiens_hsa04520 | 0.61411303 |
| 114 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61140261 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60180138 |
| 116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59274541 |
| 117 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59133428 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58227653 |
| 119 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56352944 |
| 120 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56098105 |
| 121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55616791 |
| 122 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55499580 |
| 123 | Amoebiasis_Homo sapiens_hsa05146 | 0.54559328 |
| 124 | Glioma_Homo sapiens_hsa05214 | 0.53047899 |
| 125 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51851489 |
| 126 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.51203525 |
| 127 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.50847121 |
| 128 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50083514 |
| 129 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48885954 |
| 130 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46632992 |
| 131 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.46407529 |
| 132 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.46378768 |
| 133 | Influenza A_Homo sapiens_hsa05164 | 0.46302789 |
| 134 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46143287 |
| 135 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45675605 |
| 136 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.42885098 |
| 137 | Lysine degradation_Homo sapiens_hsa00310 | 0.42490902 |
| 138 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.41978099 |
| 139 | Measles_Homo sapiens_hsa05162 | 0.41689580 |
| 140 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41613130 |
| 141 | Prion diseases_Homo sapiens_hsa05020 | 0.40047294 |
| 142 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.39311477 |
| 143 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38064839 |
| 144 | Legionellosis_Homo sapiens_hsa05134 | 0.37993661 |
| 145 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36519951 |
| 146 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.35029972 |
| 147 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33032113 |
| 148 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.30998955 |
| 149 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30279957 |
| 150 | Hepatitis B_Homo sapiens_hsa05161 | 0.29526772 |
| 151 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.28983031 |
| 152 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25723180 |

